Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines

British Journal of Cancer

Volumn 67, Issue 6, 1993, Pages 1274-1284

  Burns, J E ^a   Baird, M C ^a   Clark, L J ^a   Burns, P A ^a   Edington, K ^a   Chapman, C ^a   Mitchell, R ^b   Robertson, G ^c   Soutar, D ^c   Parkinson, E K ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c CANNIESBURN PLASTIC SURGERY UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN P53;

ARTICLE; CELL LEVEL; CELL LINE; CLINICAL ARTICLE; DELETION MUTANT; EXON; FETUS; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA SEQUENCE; RNA TRANSCRIPTION; SQUAMOUS CELL CARCINOMA; TONGUE; WART VIRUS;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; GENES, P53; HEAD AND NECK NEOPLASMS; HUMAN; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MOLECULAR SEQUENCE DATA; MOUTH; MOUTH NEOPLASMS; MUTATION; PAPILLOMAVIRUS; PROTEIN P53; SUPPORT, NON-U.S. GOV'T;

EID: 0027233830     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1993.238     Document Type: Article

References (91)

1. BAKER, S.J., FEARON, E.R., NIGRO, J.M., HAMILTON, S R., PREISINGER, A.C., JESSUP, J.M., VAN TUINEN, P., LEDBETTER, D.H., BARKER, D.F., NAKAMURA, Y., WHITE, R. & VOGELSTEIN, B. (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science, 244, 217-221.
2. BAKER, S.J., MARKOVITZ, S., FEARON, E.R., WILLSON, J.K. & VOGELSTEIN, B. (1990). Suppression of human colorectal carcinoma cell growth by wild-type p53. Science, 249, 912-915.
3. BANKS, L., MATLASHEWSKI, G. & CRAWFORD, L. (1986). Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur. J. Biochem., 259, 529-534.
4. BARTEK, J., BARTKOVA, J., VOJTESEK, B., STADKOVA, Z., REJTHAR, A., KOVARIK, J. & LANE, D.P. (1990a). Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int. J. Cancer, 46, 839-844.
5. BARTEK, J., IGGO, R., GANNON, J. & LANE, D.P. (19906). Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene, 5, 893-899.
6. BENNETT, W.P., HOLLSTEIN, M.C., HE, A., ZHU, S.M., RESAU, J.H., TRUMP, B.F., METCALF, R.A., WELSH, J.A., MIDGLEY, C., LANE, D.P. & HARRIS, C.C. (1991). Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene, 6, 1779-1784.
7. BISCHOFF, F.Z., STRONG, L.C., YIM, S O., PRATT, D R., SICILIANO, M.J., GIOVANELLA, B.C. & TAINSKY, M.A. (1991). Tumorigenic transformation of spontaneously immortalized fibroblasts from patients with a familial cancer syndrome. Oncogene, 6, 183-186.
8. BISCHOFF, F.Z., YIM, S O., PATHAK, S., GRANT, G., SICILIANO, M.J., GIOVANELLA, B.C., STRONG, L.C. & TAINSKY, M.A. (1990). Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res., 50, 7979-7984.
9. BRACHMAN, D.G., GRAVES, D., VOKES, E., BECKETT, M., HARAF, D., MONTAG, A., DUNPHY, E., MICK, R., YANDELL, D. & WEICHSELBAUM, R.R. (1992). Occurance of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res., 52, 4832-4836.
10. BRASH, D.E., RUDOLPH, J.A., SIMON, J.A., LIN, A., MCKENNA, G.J., BADEN, H.P., HALPERIN, A.J. & PONTEN, J. (1991). A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinomas. Proc. Natl Acad. Sci. USA, 88, 10124-10128.
11. CARON DE FROMENTEL, C. & SOUSSI, T. (1992). TP53 Tumor suppressor gene - a model for investigating human mutagenesis. Genes Chromosomes & Cancer, 4, 1-15.
12. CASEY, G., LU-HSUEH, M., LOPEZ, M.E., VOGELSTEIN, B. & STANBRIDGE, E.J. (1991). Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene, 6, 1791-1797.
13. CATTORETTI, G., RILKE, F., ANDRELOA, S., DAMATO, L. & DELIA, A. (1988). P53 expression in breast cancer. Int. J. Cancer, 41, 178-183.
14. CHEN, P.L., CHEN, Y., BOOKSTEIN, R. & LEE, W.H. (1990). Genetic mechanisms of tumor suppression by the human p53 gene. Science, 250, 1576-1580.
15. CHEN, Y., CHEN, P.L., ARNAIZ, N., GOODRICH, D. & LEE, W.H. (1990). Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate. Oncogene, 6, 1799-1805.
16. CHENG, J., YEE, J.K., YEARGIN, J., FRIEDMANN, T. & HASS, M. (1991). Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene. Cancer Res., 52, 222-226.
17. CHIBA, I., TAKAHASHI, T., NAU, M.M., D AMICO, D., CURIEL, D.T., MITSUDOMI, T., BUCHHAGEN, D.L., CARBONE, D., PIANTODOSI, S., KOGA, H., REISSMAN, P.T., SLAMON, D.J., HOLMES, C. & MINNA, J.D. (1990). Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5, 1603-1610.
18. CROOK, T., TIDY, J.A. & VOUSDEN, K.H. (1991a). Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and transactivation. Cell, 67, 547-556.
19. CROOK, T., WREDE, D., TIDY, J., SCHOLEFIELD, J., CRAWFORD, L. & VOUSDEN, K.H. (1991a). Status of c-myc, p53 and retinoblastoma genes in human papillomavirus positive and negative squamous cell carcinomas of the anus. Oncogene, 6, 1251-1257.
20. DILLER, L., KASSEL, J., NELSON, C.E., GRYKA, M.A., LITWAK, G., GEBHARDT, M., BRESSAC, B., OZTARK, M., BAKER, S.J., VOGELSTEIN, B. & FRIEND, S.H. (1990). p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell Biol., 10, 5772-5781.
21. DONEHOWER, L.A., HARVEY, M., SLAGLE, B.L., MCARTHUR, M.J., NTGOMERY, C.A. Jr., BUTEL, J.S. & BRADLEY, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
22. EASTY, DM., EASTY, G.C., CARTER, R.L., MONOGHAN, P. & BUTLER, L.J. (1981). Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck. Br. J. Cancer, 43, 772-785.
23. FEARON, E.R., HAMILTON, S.R. & VOGELSTEIN, B. (1987). Clonal analysis of human colorectal tumours. Science, 238, 193-197.
24. FIELD, J.K., SPANDIDOS, D.A., MALLIRI, A., GOSNEY, J R., YIAGNISIS, M. & STELL, P.M. (1991). Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br. J. Cancer, 64, 573-577.
25. FINLAY, C.A., HINDS, P.W. & LEVINE, A.J. (1989). The p53 protooncogene can act as a suppressor of transformation. Cell, 57, 1083-1093.
26. FINLAY, C.A., HINDS, P.W., TAN, T.H., ELIYAHU, D., OREN, M. & LEVINE, A.J. (1988). Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol., 8, 531-539.
27. GORDON, A.J.E., BURNS, P.A., FIX, D.F., YATAGAI, F., ALLEN, F.L., HORSFALL, M.J., HALLIDAY, J.A., GRAY, J., BERNELOT-MOENS, C. & GLICKMAN, B.W. (1988). Missense mutation in the lacl gene of Escherichia coli. Inferences on the structure of the repressor protein. J. Mol. Biol., 200, 239-251.
28. GREEN, H. (1978). Cyclic AMP in relation to proliferation of the epidermal cell: a new view. Cell, 15, 801-811.
29. GUSTERSON, B.A., ANBAZHAGAN, R., WARREN, W., MIDGELY, C., LANE, D.P., O’HARE, M., STAMPS, A., CARTER, R. & JAYATILAKE, H. (1991). Expression of p53 in premalignant and malignant squamous epithelium. Oncogene, 6, 1785-1789.
30. HALEVY, O., MICHAELOVITZ, D. & OREN, M. (1990). Different tumor-derived p53 mutants exhibit distinct biological activities. Science, 250, 113-116.
31. HARVEY, D.M. & LEVINE, A.J. (1991). p53 alteration is a common event in the spontaneous immortalisation of primary BALB. C murine embryo fibroblasts. Genes & Development, 5, 2375-2385.
32. HAWLEY-NELSON, P., VOUSDEN, K.H., HUBBERT, N.L., LOWY, D R. & SCHILLER, J.T. (1989). HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J., 8., 3905-3910.
33. HOLLSTEIN, M., METCALF, R.A., WELSH, J.A., MONTESANO, R. & HARRIS, C.C. (1990). Frequent mutation of the p53 gene in human esophegeal cancer. Proc. Natl Acad. Sci. USA, 87, 9958-9961.
34. HOLLSTEIN, M., SIDRANSKY, D., VOGELSTEIN B. & HARRIS, C.C. (1991). p53 mutations in human cancers. Science, 253, 49-53.
35. HUNTER, T. (1991). Cooperation between oncogenes. Cell, 64, 249-270.
36. HURLIN, P.J., KAUR, P., SMITH, P.P., PEREZREYES, N., BLANTON, R.A. & MCDOUGALL, J.K. (1991). Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype. Proc. Natl Acad. Sci. USA, 88, 570-574.
37. IARC (1986). Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 38, Tobacco Smoking IARC Lyon.
38. IGGO, R., GATTER, K., BARTER, J., LANE, D. & HARRIS, A.L. (1990). Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335, 675-679.
39. JONES, P.A., BUCKLEY, J.D., HENDERSON, B E., ROSS, R.K. & PIKE, M.C. (1991). From gene to carcinogen: a rapidly evolving field in molecular epidemiology. Cancer Res., 51, 3617-3620.
40. JUNG, M., NOTARIO, V. & DRITSCHILO, A. (1992). Mutations in the p53 gene in radiation-sensitive and -resistant human squamous carcinoma cells. Cancer Res., 52, 6390-6393.
41. KAUR, P. & MCDOUGALL, J.K. (1988). Characterization of primary keratinocytes transformed by human papillomavirus type 18. J. Virol., 62, 1917-1924.
42. LANE, D.P. & CRAWFORD, L.V. (1979). T antigen is bound to a host protein in SV40 transformed cells. Nature, 278, 261-263.
43. LAW, J.C., STRONG, L.C., CHIDAMBARAM, A. & FERRELI, R E. (1991). A germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Res., 51, 6385-6387.
44. LI, F.P. & FRAUMENI, J.F. Jr. (1969). Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J. Natl Cancer Inst., 43, 1365-1373.
45. LINZER, D.I. & LEVINE, A.J. (1979). Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell, 17, 43-52.
46. LONING, T., IKENBERG, H., BECKER, J., GISSMAN, L., HOEPFNER, I. & ZUR HAUSEN, H. (1985). Analysis of oral papillomas, leukoplakias and invasive carcinomas for human papillomavirus type related DNA. J. Invest. Dermatol., 88, 417-420.
47. LU, X., PARK, S.H., THOMPSON, T. & LANE, D.P. (1992). ras-induced hyperplasia occurs with mutation of p53 but activated ras and myc together can induce carcinoma without p53 mutation. Cell, 70, 153-161.
48. MAESTRO, R., DOLCETTI, R., GASPAROTTO, C., DOGLIONI, C., PELUCCHI, S., BARZAN, L., GRANDI, E. & BOIOCCHI, M. (1992). High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene, 7, 1159-1166.
49. MAITLAND, N.J., COX, M.F., LYNAS, C., PRIME, S.S. & SCULLY, C. (1987). Detection of human papillomavirus DNA in biopsies of human oral tissue. Br. J. Cancer, 56, 245-250.
50. MAITLAND, N.J., BROMIDGE, T., COX, M.F., CRANE, I.J., PRIME, S.S. & SCULLY, C. (1989). Detection of human papillomavirus genes in human oral tissue biopsies and cultures by polymerase chain reaction. Br. J. Cancer, 59, 698-703.
51. MALKIN, D., LI, F.P., STRONG, L.C., FRAUMENI, J.F. Jr., NELSON, C., KIM, D. M., KASSEL, J., GRYKA, M. A., BISCHOFF, F. Z., TAINSKY, M. A. & FRIEND, S. H. (1990). Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science, 250, 1233-1238.
52. MERCER, W.E., SHIELDS, M.T., AMIN, M., SAUVE, G.J., APPELLA, E., ROMANO, J.W. & ULLRICH, S.J. (1990). Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild type p53. Proc. Natl Acad. Sci. USA, 87, 6166-6170.
53. MICHAELOVITZ, D., HALEVY, O. & OREN, M. (1990). Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell, 62, 671-680.
54. MILNER, J. & MEDCALF, E.A. (1991). Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell, 65, 765-774.
55. MITSUDOMI, T., STEINBERG, S.M., NAU, M.M., CARBONE, D., D AMICO, D., BODNER, S., OIE, H.K., LINNIOLA, I., MULSHINE, J.L., MINNA, J.D. & GAZDAR, A.F. (1992). p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene, 7, 171-180.
56. MUNGER, K., PHELPS, W.C., BUBB, V., HOWLEY, P.M. & SCHEGEL, R. (1989). The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol., 63, 4417-4421.
57. NEWBOLD, R.F. (1985). Multistep malignant transformation of mammalian cells by carcinogens: induction of immortality as a key event. In Carcinogenesis: a Comprehensive Survey Vol. 9 Mammalian Cell Transformation: Mechanisms of Carcinogenesis and Assays for Carcinogens pp. 17-28. Barratt, J.C. & Tennant, R.W. (eds.) Raven Press: New York.
58. NIGRO, J.M., BAKER, S.J., PREISINGER, A.C., JESSUP, J.M., HOSTETTER, R., CLEARY, K., BIGNER, S. H., DAVIDSON, N., BAYLIN, S., DEVILEE, P., GLOVER, T., COLLINS, F. S., WESTON, A., MODALI, R., HARRIS, C. C. & VOGELSTEIN, B. (1989). Mutations in the p53 gene occur in diverse human tumour types. Nature, 342, 705-708.
59. OLINER, J.D., KINZLER, K.W., MELTZER, P.S., GEORGE, D.L. & VOGELSTEIN, B. (1992). Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature, 358, 80-83.
60. OREN, M., MALTZMAN, W. & LEVINE, A.J. (1981). Post-translational regulation of the 54K cellular antigen in normal and transformed cells. Mol. Cell Biol., 1, 101-110.
61. PARK, N.H., MIN, B.M., LI, S.L., HUANG, M.Z., CHERICK, H.M. & DONIGER, J. (1991). Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis, 12, 1627-1631.
62. PARKINSON, E.K., GRABHAM, P. & EMMERSON, A. (1983). A subpopulation of cultured human keratinocytes which is resistant to the induction of terminal differentiation-related changes by phor- bol, 12-myristate, 13-acetate: evidence for an increase in the resistant population following transformation. Carcinogenesis, 4, 857-861.
63. PARKINSON, E.K., HUME, W.J. & POTTEN, C.S. (1986). The radiosensitivity of cultured human and mouse keratinocytes. Int. J. Rad. Biol., 50, 717-726.
64. PATER, M.M. & PATER, A. (1985). Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology, 145, 313-318.
65. PIERCEALL, W.E., MUKHOPADHYAY, T., GOLDBERG, L.H. & ANANTHASWAMY, H.N. (1991). Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas. Mol. Carcinog., 4, 445-449.
66. PIRISI, L., YASUMOTO, S., FELLER, M., DONIGER, J. & DIPAULO, J.A. (1987). Transformation of human fibroblasts and keratinocytes with human papillomasvirus type 16 DNA. J. Virol., 61, 1061-1066.
67. PURDIE, C.A., OGRADY, J., PIRIS, J., WYLLIE, A.H. & BIRD, C.C. (1991). p53 expression in colorectal tumors. Am. J. Pathol., 138, 807-813.
68. RHEINWALD, J.G. & BECKETT, M.A. (1980). Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell, 22, 629-632.
69. RHEINWALD, J.G. & BECKETT, M.A. (1981). Tumourigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res., 41, 1657-1663.
70. RHEINWALD, J.G. & GREEN, H. (1975). Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell, 6, 331-343.
71. RIDEOUT, W.M., III, COETZEE, G.A., OLUMI, A.F. & JONES, P.A., (1990). 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science, 249, 1288-1290.
72. RODRIGUES, N.R., ROWAN, A., SMITH, M.E.F., KERR, I.B., BODMER, W.F., GANNON, J.V. & LANE, D.P. (1990). p53 mutations in colorectal cancer. Proc. Natl Acad. Sci. USA, 87, 7555-7559.
73. RONEN, D., ROTTER, V. & REISMAN, D. (1991). Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif. Proc. Natl Acad. Sci. USA, 88, 4128-4132.
74. SAKAI, E. & TSUCHIDA, N. (1992). Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor- suppressor genes. Oncogene, 7, 927-933.
75. SARNOW, P., HO, Y.S., WILLIAMS, J. & LEVINE, A.J. (1982). Adenovirus Elb-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in mammalian cells. Cell, 28, 387-394.
76. SCHEFFNER, M., MUNGER, K., BYRNE, J.C. & HOWLEY, P. M., (1991). The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl Acad. Sci, USA, 88, 5523-5527.
77. SCHEFFNER, M., WERNESS, B.A., HUMBREGTSE, J.M., LEVINE, A.J. & HOWLEY, P.M. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136.
78. SRIVASTAVA, S., ZOU, Z.Q., PIROLLO, K., BLATTNER, W.A. & CHANG, E.H. (1990). Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature, 348, 747-749.
79. STELL, P.M. (1972). Smoking and laryngeal cancer. Lancet, i, 617-618.
80. UICC (1987) Union Internationale Contre le Cancer TNM Classification of Malignant Tumours Hermanele, P. & Fobin, L. (eds.) Springer Verlag, Berlin.
81. ULRICH, E., BOEHMELT, G., BIRD, A. & BEUG, H. (1992). Immortalization of conditionally transformed chicken cells: loss of normal p53 expression is an early step that is independent of cell transformation. Genes & Develop., 6, 876-887.
82. VAN DER BERG, F.M., TIGGES, A.J., SCHIPPER, M.E., DEN HARTOGJAGER, F.C.A., KROES, W.G.M. & WALBOOMERS, J.M.M. (1989). Expression of the nuclear oncogene p53 in colon tumours. J. Pathol., 157, 193-199.
83. VOGELSTEIN, B., FEARON, E.R., HAMILTON, S R., KERN, S.E., PREISINGER, A C., LEPPART, M., NAKAMURA, Y., WHITE, R., SMITS, A.M. & BOS, J.L. (1988). Genetic alterations during colorectal-tumor development. New Eng. J. Med., 319, 525-532.
84. VOGELSTEIN, B. & KINZLER, K.W. (1992). p53 function and dysfunction. Cell, 70, 523-526.
85. WEINBERG, R.A. (1989). Oncogene, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res., 49, 3713-3721.
86. WERNESS, B.A., LEVINE, A.J. & HOWLEY, P.M. (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 248, 76-79.
87. WESTON, A., WILLEY, J.C., MODALI, R., SUGIMURA, H., MCDOWELL, E.M., RESAN, J., LIGHT, B., HAUGEN, A., MANN, L., TRUMP, B.F. & HARRIS, C.C. (1989). Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc. Natl Acad. Sci. USA, 86, 5099-5103.
88. WOLF, D., HARRIS, N. & ROTTER, V. (1984). Reconstitution of p53 expression in a non producer Ab-MuLV-transformed cell line by transfection of a functional p53 gene. Cell, 38, 119-126.
89. YEUDALL, W.A. & CAMPO, M.S. (1991). Human papillomavirus DNA in biopsies of oral tissues. J. Gen. Virol., 72, 173-176.
90. YOKOTA, J., TSUNETSUGUYOKOTA, Y., BATTIFORA, H., LE FEVRE, C. & CLINE, M.J. (1986). Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. Science, 231, 261-265.
91. YOKOTA, J., WADA, M., SHIMOSATO, Y., TERADA, M. & SUGIMURA, T. (1987). Loss of heterozygosity of chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc. Natl Acad. Sci. USA, 84, 9252-9256.